| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/10/2005 | WO2005012499A2 Methods for amplifying polymeric nucleic acids |
| 02/10/2005 | WO2005012492A2 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | WO2005012487A2 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 02/10/2005 | WO2005012483A2 Vpr selective rnai agents and methods for using the same |
| 02/10/2005 | WO2005012359A2 Anti-vegf antibodies |
| 02/10/2005 | WO2005012351A2 Novel functions for decay accelerating factor (daf) in inflammation |
| 02/10/2005 | WO2005011580A2 Compositions and methods for herpes simplex prophylaxis and treatment |
| 02/10/2005 | WO2004106489A3 Nematode GS-like sequences |
| 02/10/2005 | WO2004092397A3 Tmprss2 regulatory sequences and uses thereof |
| 02/10/2005 | WO2004065440B1 Cationic graft-copolymer for non-viral gene delivery vector |
| 02/10/2005 | WO2004044139A3 Modified oligonucleotides for use in rna interference |
| 02/10/2005 | WO2004043332A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 02/10/2005 | WO2004039469A3 Process of purifying phosphoramidites |
| 02/10/2005 | WO2004038007A3 Dna polymerases with reduced base analog detection activity |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2004019001A3 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2003025117A3 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 02/10/2005 | US20050033031 Methods for humanizing rabbit monoclonal antibodies |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032729 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
| 02/10/2005 | US20050032723 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/10/2005 | US20050032223 Generating site directed DNA breaks in transformed cells via expression of heterologous endonuclease; bioreactor for generating exogenous proteins; gene therapy |
| 02/10/2005 | US20050032184 Disorazole polyketide synthase encoding polynucleotides |
| 02/10/2005 | US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders |
| 02/10/2005 | US20050032173 Chimeric protein comprising I kappa B protein domains for use in prevention and treatment of skin, inflammatory, autoimmune, respiratory, cell proliferative and allergic disorders; immunosuppressant |
| 02/10/2005 | US20050032171 hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032166 Expression vector comprising nucleotide sequences coding adipokine binding protein for use in treatment and prevention of diabetes, obesity, inflammation, cardiovascular and metabolic disorders |
| 02/10/2005 | US20050032164 IL4 receptor antagonists for horse, dog and cat |
| 02/10/2005 | US20050032146 Tssk4: a human testis specific serine/threonine kinase |
| 02/10/2005 | US20050032134 Neoplasm-specific polypeptides and their uses |
| 02/10/2005 | US20050032095 Virtual representations of nucleotide sequences |
| 02/10/2005 | US20050032090 Detection of Giardia |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032081 Solid phase synthesis; biocatalysts |
| 02/10/2005 | US20050032070 Polymorphisms in the human gene for CYP2D6 and their use in diagnostic and therapeutic applications |
| 02/10/2005 | US20050032069 RNA-induced silencing complexes; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032068 Oligomers hybridize with each other, one of which includes peptide nucleic acid or mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid or an acyclic backbone modification; gene expression inhibition |
| 02/10/2005 | US20050032067 Nucleosides; RNA-induced silencing complex; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032055 Methods of making nucleic acid molecules with reduced secondary structure |
| 02/10/2005 | US20050032053 Hydrogen bonding; hybridization; synthesized via RNA/DNA polymerase reverse transcriptase, ribozyme, and/or self-replicating RNA molecule |
| 02/10/2005 | US20050031649 Bacillus Calmette Guerin (BCG) heat shock protein; treating breast cancer, ovarian cancer, colon cancer, prostate cancer and lung cancer |
| 02/10/2005 | US20050031629 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 02/10/2005 | US20050031617 Antibodies specific for cancer associated antigen SM5-1 and uses thereof |
| 02/10/2005 | US20050031607 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 02/10/2005 | US20050031593 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 02/10/2005 | US20050031582 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 02/10/2005 | CA2820028A1 Multimeric oxidoreductases |
| 02/10/2005 | CA2534055A1 Antibody cdr polypeptide sequences with restricted diversity |
| 02/10/2005 | CA2533938A1 Multimeric oxidoreductases |
| 02/10/2005 | CA2533936A1 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 02/10/2005 | CA2533305A1 Methods for amplifying polymeric nucleic acids |
| 02/10/2005 | CA2533297A1 Anti-vegf antibodies |
| 02/09/2005 | EP1505160A2 5'nucleases derived from thermostable DNA polymerase |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504099A2 Novel nucleic acids and polypeptides |
| 02/09/2005 | EP1504049A1 Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 02/09/2005 | EP1504034A1 Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 02/09/2005 | EP1504018A2 Simple catalytic dna biosensors for ions based on color changes |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1339870B1 Methods for external controls for nucleic acid amplification |
| 02/09/2005 | EP1313885A4 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 02/09/2005 | EP1162982B1 USE OF STABILISED OLIGONUCLEOTIDES FOR PREPARING A MEDICament WITH ANTITUMOUR ACTIVITY |
| 02/09/2005 | EP0885238A4 Substituted nucleic acid mimics |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | CN1578841A Annealing control primer and the use of the same annealing control primer |
| 02/09/2005 | CN1578840A Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 02/09/2005 | CN1576366A A hematopoietic cell specific cell cycle control gene and its coded protein |
| 02/08/2005 | US6852850 Use of ionic liquids for fabrication of polynucleotide arrays |
| 02/08/2005 | US6852848 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/08/2005 | US6852840 Human kielin-like proteins and polynucleotides encoding the same |
| 02/08/2005 | US6852832 Single stranded DNA binding proteins from archaea |
| 02/08/2005 | US6852704 Compositions and methods for reverse gene therapy, wherein a gene therapy vector encoding a gene product (e.g. a protein) which is usually only expressed in cells of an abnormal tissue is delivered to a cell of an animal afflicted with a disease |
| 02/08/2005 | US6852535 A transcribed non-naturally occurring RNA molecule comprising a desired RNA molecule, wherein the 3' region of the RNA is able to base-pair with at least 8 bases at the 5' terminus of the same RNA molecule |
| 02/08/2005 | US6852529 Gloucose-regulated mRNA instability element |
| 02/08/2005 | US6852488 Identifying a base in a nucleic acid |
| 02/08/2005 | US6852322 Surface proteins of Leptospira |
| 02/08/2005 | CA2201756C Self-quenching fluorescence probe and method |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/03/2005 | WO2005010205A2 Biomarkers fo aggrecanase activity |
| 02/03/2005 | WO2005010204A2 Rapid nucleic acid isolation method and compositions therefore |
| 02/03/2005 | WO2005010203A2 Treatment of cells for fluorescence in situ hybridization |
| 02/03/2005 | WO2005010201A2 Methods and compositions for detecting nucleic acid sequences |
| 02/03/2005 | WO2005010197A2 A systemic small rna signaling system in plants |
| 02/03/2005 | WO2005010191A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | WO2005010156A2 Genes encoding carotenoid compounds |
| 02/03/2005 | WO2005010148A2 Marks as modifiers of the pten pathway and methods of use |
| 02/03/2005 | WO2005010145A2 Method and compositions for detection and enumeration of genetic variations |
| 02/03/2005 | WO2005010142A2 Plant centromere compositions |
| 02/03/2005 | WO2005010141A2 Compositions for purifying and crystallizing molecules of interest |
| 02/03/2005 | WO2005010016A2 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 02/03/2005 | WO2005009597A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 02/03/2005 | WO2005009476A1 Intravascular delivery of non-viral nucleic acid |
| 02/03/2005 | WO2005009369A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |